141 related articles for article (PubMed ID: 29085505)
1. Diagnostic value of serum bile acid composition patterns and serum glycocholic acid levels in cholangiocarcinoma.
Proungvitaya S; Sombattheera S; Boonsiri P; Limpaiboon T; Wongkham S; Wongkham C; Titapun A; Proungvitaya T
Oncol Lett; 2017 Oct; 14(4):4943-4948. PubMed ID: 29085505
[TBL] [Abstract][Full Text] [Related]
2. Discovery of glycocholic acid and taurochenodeoxycholic acid as phenotypic biomarkers in cholangiocarcinoma.
Song WS; Park HM; Ha JM; Shin SG; Park HG; Kim J; Zhang T; Ahn DH; Kim SM; Yang YH; Jeong JH; Theberge AB; Kim BG; Lee JK; Kim YG
Sci Rep; 2018 Jul; 8(1):11088. PubMed ID: 30038332
[TBL] [Abstract][Full Text] [Related]
3. Serum cathepsin B to cystatin C ratio as a potential marker for the diagnosis of cholangiocarcinoma.
Monsouvanh A; Proungvitaya T; Limpaiboon T; Wongkham C; Wongkham S; Luvira V; Proungvitaya S
Asian Pac J Cancer Prev; 2014; 15(21):9511-5. PubMed ID: 25422248
[TBL] [Abstract][Full Text] [Related]
4. Total serum bile acid as a potential marker for the diagnosis of cholangiocarcinoma without jaundice.
Sombattheera S; Proungvitaya T; Limpaiboon T; Wongkham S; Wongkham C; Luvira V; Proungvitaya S
Asian Pac J Cancer Prev; 2015; 16(4):1367-70. PubMed ID: 25743800
[TBL] [Abstract][Full Text] [Related]
5. Bile-derived circulating extracellular miR-30d-5p and miR-92a-3p as potential biomarkers for cholangiocarcinoma.
Han HS; Kim MJ; Han JH; Yun J; Kim HK; Yang Y; Kim KB; Park SM
Hepatobiliary Pancreat Dis Int; 2020 Feb; 19(1):41-50. PubMed ID: 31784323
[TBL] [Abstract][Full Text] [Related]
6. Analysis of bile acid profile in plasma to differentiate cholangiocarcinoma from benign biliary diseases and healthy controls.
Zhang X; Yang Z; Shi Z; Zhu Z; Li C; Du Z; Zhang Y; Wang Z; Jiao Z; Tian X; Zhang J; Zhai W; Kan Q
J Steroid Biochem Mol Biol; 2021 Jan; 205():105775. PubMed ID: 33130021
[TBL] [Abstract][Full Text] [Related]
7. The Role of Resolvin D1 in the Differential Diagnosis of the Cholangiocarcinoma and Benign Biliary Diseases.
Gül-Utku Ö; Karatay E; Ergül B; Kisa Ü; Erdin Z; Oğuz D
Clin Lab; 2020 May; 66(5):. PubMed ID: 32390401
[TBL] [Abstract][Full Text] [Related]
8. High expression of protein tyrosine phosphatase receptor S (PTPRS) is an independent prognostic marker for cholangiocarcinoma.
Lertpanprom M; Silsirivanit A; Tippayawat P; Proungvitaya T; Roytrakul S; Proungvitaya S
Front Public Health; 2022; 10():835914. PubMed ID: 35991009
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and Prognostic Value of Circulating Cell-Free DNA for Cholangiocarcinoma.
Wintachai P; Lim JQ; Techasen A; Lert-Itthiporn W; Kongpetch S; Loilome W; Chindaprasirt J; Titapun A; Namwat N; Khuntikeo N; Jusakul A
Diagnostics (Basel); 2021 May; 11(6):. PubMed ID: 34070951
[TBL] [Abstract][Full Text] [Related]
10. Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma.
Chanakankun R; Proungvitaya T; Chua-On D; Limpaiboon T; Roytrakul S; Jusakul A; Titapun A; Jarearnrat A; Proungvitaya S
Oncol Lett; 2020 Jan; 19(1):930-942. PubMed ID: 31897206
[TBL] [Abstract][Full Text] [Related]
11. Total serum bile acids or serum bile acid profile, or both, for the diagnosis of intrahepatic cholestasis of pregnancy.
Manzotti C; Casazza G; Stimac T; Nikolova D; Gluud C
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012546. PubMed ID: 31283001
[TBL] [Abstract][Full Text] [Related]
12. Serum adhesion molecule-1 (ICAM-1) as a potential prognostic marker for cholangiocarcinoma patients.
Janan M; Proungvitaya S; Limpaiboon T; Proungvitaya T; Roytrakul S; Wongkham C; Jearanaikoon P; Chur-in S; Wongkham S
Asian Pac J Cancer Prev; 2012; 13 Suppl():107-14. PubMed ID: 23480771
[TBL] [Abstract][Full Text] [Related]
13. Plasma hydroxyproline, MMP-7 and collagen I as novel predictive risk markers of hepatobiliary disease-associated cholangiocarcinoma.
Prakobwong S; Charoensuk L; Hiraku Y; Pinlaor P; Pairojkul C; Mairiang E; Sithithaworn P; Yongvanit P; Khuntikeo N; Pinlaor S
Int J Cancer; 2012 Aug; 131(4):E416-24. PubMed ID: 21935919
[TBL] [Abstract][Full Text] [Related]
14. High Bile Titer and High Bile to Serum Ratio of CYFRA 21 - 1 Reliably Discriminate Malignant Biliary Obstruction Caused by Cholangiocarcinoma.
Chen J; Liang J; Xu B; Liang J; Ma M; Wang Z; Zeng G; Xu Q; Liang L; Lai J; Huang L
J Gastrointest Cancer; 2024 Jun; 55(2):800-808. PubMed ID: 38280173
[TBL] [Abstract][Full Text] [Related]
15. Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma.
Sanmai S; Proungvitaya T; Limpaiboon T; Chua-On D; Seubwai W; Roytrakul S; Wongkham S; Wongkham C; Somintara O; Sangkhamanon S; Proungvitaya S
Oncol Lett; 2019 Jun; 17(6):5275-5282. PubMed ID: 31186744
[TBL] [Abstract][Full Text] [Related]
16. Serum α1β-glycoprotein and afamin ratio as potential diagnostic and prognostic markers in cholangiocarcinoma.
Tolek A; Wongkham C; Proungvitaya S; Silsirivanit A; Roytrakul S; Khuntikeo N; Wongkham S
Exp Biol Med (Maywood); 2012 Oct; 237(10):1142-9. PubMed ID: 23104505
[TBL] [Abstract][Full Text] [Related]
17. Early and accurate detection of cholangiocarcinoma in patients with primary sclerosing cholangitis by methylation markers in bile.
Vedeld HM; Grimsrud MM; Andresen K; Pharo HD; von Seth E; Karlsen TH; Honne H; Paulsen V; Färkkilä MA; Bergquist A; Jeanmougin M; Aabakken L; Boberg KM; Folseraas T; Lind GE
Hepatology; 2022 Jan; 75(1):59-73. PubMed ID: 34435693
[TBL] [Abstract][Full Text] [Related]
18. Bile and urine peptide marker profiles: access keys to molecular pathways and biological processes in cholangiocarcinoma.
Voigtländer T; Metzger J; Husi H; Kirstein MM; Pejchinovski M; Latosinska A; Frantzi M; Mullen W; Book T; Mischak H; Manns MP
J Biomed Sci; 2020 Jan; 27(1):13. PubMed ID: 31900160
[TBL] [Abstract][Full Text] [Related]
19. State of serum markers for detection of cholangiocarcinoma.
Wongkham S; Silsirivanit A
Asian Pac J Cancer Prev; 2012; 13 Suppl():17-27. PubMed ID: 23480761
[TBL] [Abstract][Full Text] [Related]
20. Assessment of bile and serum mucin5AC in cholangiocarcinoma: diagnostic performance and biologic significance.
Danese E; Ruzzenente O; Ruzzenente A; Iacono C; Bertuzzo F; Gelati M; Conci S; Bendinelli S; Bonizzato G; Guglielmi A; Salvagno GL; Lippi G; Guidi GC
Surgery; 2014 Nov; 156(5):1218-24. PubMed ID: 25151557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
